Loading...

GSK

GSK

GSK PLC

(GSK)

2026 6-K

Director Shareholding

1 Apr '26

Voting Rights Update

1 Apr '26

Share Buyback Announcement

1 Apr '26

Shareholding Update

1 Apr '26

Share Buyback Announcement

31 Mar '26

Drug Review Acceptance

30 Mar '26

Asthma Drug Approval

30 Mar '26

Share Buyback Announcement

30 Mar '26

Share Buyback Update

27 Mar '26

EMA Review Accepted

27 Mar '26

Share Buyback Announcement

26 Mar '26

Director Shareholding

25 Mar '26

Annual Meeting Notice

25 Mar '26

Share Buyback Alert

25 Mar '26

Share Buyback Completed

24 Mar '26

Director Shareholding

23 Mar '26

Share Admission Notice

23 Mar '26

Orphan Drug Designation

23 Mar '26

Share Buyback Announcement

23 Mar '26

Share Buyback Announcement

20 Mar '26

FDA Approval Granted

19 Mar '26

Share Buyback Update

19 Mar '26

Director Shareholding

18 Mar '26

Share Buyback Announced

18 Mar '26

Director Shareholding

17 Mar '26

Share Buyback Announcement

17 Mar '26

Share Buyback Announcement

16 Mar '26

Vaccine Approval

13 Mar '26

Share Buyback Update

13 Mar '26

Share Acquisition Update

12 Mar '26

Share Buyback Announcement

12 Mar '26

Share Buyback Update

11 Mar '26

Share Buyback Announcement

10 Mar '26

Board Committee Change

9 Mar '26

Global Rights Agreement

9 Mar '26

Share Buyback Update

9 Mar '26

Annual Report Filing

6 Mar '26

Share Buyback Announced

6 Mar '26

Annual Report Published

5 Mar '26

Share Buyback Announcement

5 Mar '26

Director Shareholding

4 Mar '26

Share Buyback Announcement

4 Mar '26

Acquisition Complete

3 Mar '26

Share Buyback Announcement

3 Mar '26

Share Buyback Activity

2 Mar '26

Voting Rights Update

2 Mar '26

Shareholding Update

27 Feb '26

Share Buyback Update

27 Feb '26

Linerixibat Review

26 Feb '26

Regulatory Filing

26 Feb '26

Share Buyback Announcement

26 Feb '26

PDMR Shareholding Update

25 Feb '26

Director Shareholding Update

25 Feb '26

GSK Acquisition Announcement

25 Feb '26

Share Buyback Update

25 Feb '26

Director Shareholding

24 Feb '26

Share Buyback Update

24 Feb '26

Share Buyback Program

23 Feb '26

Director Shareholding

20 Feb '26

Share Buyback Announcement

20 Feb '26

Director Shareholding

19 Feb '26

Share Buyback Announcement

19 Feb '26

Share Buyback Update

18 Feb '26

Director Shareholding Notif...

17 Feb '26

Performance Awards Vested

17 Feb '26

Share Buyback Update

17 Feb '26

EU Approval Granted

17 Feb '26

Share Awards Granted

17 Feb '26

Bonus Share Awards

17 Feb '26

Managerial Awards

17 Feb '26

Director Shareholdings

11 Feb '26

Share Vesting Notification

11 Feb '26

Director Shareholding

11 Feb '26

Share Awards Vesting

11 Feb '26

GSK Vaccine Review

10 Feb '26

Director Shareholding

9 Feb '26

Share Purchase Notification

6 Feb '26

Nucala Approved

6 Feb '26

Director Shareholding

5 Feb '26

Strong 2025 Performance

4 Feb '26

Voting Rights Update

2 Feb '26

Vaccine Approval

26 Jan '26

GSK Acquisition

20 Jan '26

Shareholding Change

20 Jan '26

Director Shareholding

16 Jan '26

Share Acquisition Report

15 Jan '26

Share Acquisition Notification

13 Jan '26

Shingrix Approval

7 Jan '26

Positive Trial Results

7 Jan '26

Approval in Japan

6 Jan '26

Share Acquisition Notification

5 Jan '26

Total Voting Rights

5 Jan '26

Nucala Approved China

5 Jan '26

Drug Price Reduction

23 Dec '25

Director Share Purchases

22 Dec '25

Share Buyback Update

22 Dec '25

Share Buyback Update

19 Dec '25

Share Buyback Announcement

18 Dec '25

FDA Approval Announcement

17 Dec '25

Share Buyback Announcement

17 Dec '25

UK Approval of Exdensur

16 Dec '25

Share Buyback Details

16 Dec '25

Share Buyback Action

15 Dec '25

Positive CHMP Opinion

12 Dec '25

Nucala Approval Opinion

12 Dec '25

Positive CHMP Opinion

12 Dec '25

Share Buyback Update

12 Dec '25

FDA Approval Announcement

11 Dec '25

Share Acquisition Notification

11 Dec '25

Block Listing Application

11 Dec '25

Share Buyback Announcement

11 Dec '25

Share Buyback Update

10 Dec '25

FDA Designation Granted

10 Dec '25

Share Sale Notification

9 Dec '25

Share Buyback Update

9 Dec '25

Share Buyback Announcement

8 Dec '25

Share Buyback Update

5 Dec '25

Share Buyback Report

4 Dec '25

Share Buyback Details

3 Dec '25

Share Buyback Update

2 Dec '25

Director Shareholding

1 Dec '25

Voting Rights Update

1 Dec '25

Share Buyback Update

1 Dec '25

Share Buyback Announcement

28 Nov '25

Share Buyback Announcement

28 Nov '25

Share Buyback Announcement

26 Nov '25

Share Buyback Update

25 Nov '25

Litigation Initiated

21 Nov '25

Share Buyback Announcement

21 Nov '25

Share Buyback Announcement

20 Nov '25

Share Transfer Announcement

19 Nov '25

Share Buyback Activity

19 Nov '25

Director Shareholding

18 Nov '25

Share Buyback Announced

18 Nov '25

Share Buyback Details

17 Nov '25

Share Buyback Update

14 Nov '25

Director Shareholdings

13 Nov '25

Share Buyback Announcement

13 Nov '25

Block Listing Review

12 Nov '25

Share Buyback Update

12 Nov '25

Share Buyback Update

12 Nov '25

Dividend Dates Announced

10 Nov '25

Share Buyback Activity

10 Nov '25

Share Buyback Update

7 Nov '25

Share Buyback Announcement

6 Nov '25

Share Buyback Announcement

5 Nov '25

Share Buyback Announcement

4 Nov '25

Voting Rights Update

3 Nov '25

Share Buyback Announcement

3 Nov '25

Share Buyback Initiated

31 Oct '25

Shareholder Transactions

30 Oct '25

Share Buyback Update

30 Oct '25

Share Buyback Program

29 Oct '25

Strong Q3 Results

29 Oct '25

Share Buyback Report

28 Oct '25

Orphan Drug Designation

28 Oct '25

Share Buyback Update

27 Oct '25

FDA Approval News

24 Oct '25

Share Buyback Completed

24 Oct '25

Share Buyback Update

23 Oct '25

Positive Inhaler Data

22 Oct '25

Share Buyback Update

22 Oct '25

Latozinemab Update

22 Oct '25

Positive CHMP Opinion

21 Oct '25

Share Buyback Announcement

21 Oct '25

Positive Phase III Results

21 Oct '25

Share Buyback Announcement

20 Oct '25

Share Buyback Announcement

17 Oct '25

Share Acquisition Details

16 Oct '25

Share Buyback Notification

16 Oct '25

Director Shareholding

15 Oct '25

Share Buyback Announcement

15 Oct '25

Shingrix Approval

14 Oct '25

Share Buyback Announcement

14 Oct '25

Director Shareholding

14 Oct '25

Share Buyback Announcement

14 Oct '25

Insider Share Acquisitions

10 Oct '25

Share Buyback Event

10 Oct '25

Share Buyback Announcement

9 Oct '25

Share Buyback Update

8 Oct '25

Share Buyback Announcement

7 Oct '25

Share Buyback Update

6 Oct '25

Share Buyback Update

3 Oct '25

Share Buyback Announcement

2 Oct '25

Voting Rights Update

1 Oct '25

Share Buyback Activity

1 Oct '25

Share Buyback Update

30 Sep '25

CEO Appointment

29 Sep '25

Share Purchases Report

22 Sep '25

Share Buyback Update

19 Sep '25

Share Purchase Announcement

18 Sep '25

GSK Investment Plans

17 Sep '25

Share Buyback Announcement

17 Sep '25

Share Buyback Announcement

16 Sep '25

Share Buyback Update

15 Sep '25

Share Buyback Announcement

12 Sep '25

Share Buyback Update

11 Sep '25

Director Shareholding Update

10 Sep '25

Share Buyback Announcement

10 Sep '25

Share Buyback Announcement

9 Sep '25

Share Buyback Announcement

8 Sep '25

Share Buyback Announcement

5 Sep '25

Share Award Notification

4 Sep '25

Share Buyback Announcement

4 Sep '25

Share Buyback Announcement

3 Sep '25

Share Buyback Report

2 Sep '25

Voting Rights Update

2 Sep '25

Share Buyback Update

2 Sep '25

Share Buyback Update

29 Aug '25

Share Buyback

28 Aug '25

Share Buyback Update

27 Aug '25

Share Buyback Announcement

26 Aug '25

Share Buyback Announcement

22 Aug '25

Shareholding Update

21 Aug '25

Share Buyback Report

21 Aug '25

Share Buyback Update

20 Aug '25

Equity Acquisition

19 Aug '25

Share Buyback Update

19 Aug '25

Share Buyback Activity

18 Aug '25

Share Buyback Update

15 Aug '25

Share Buyback Announcement

14 Aug '25

Share Buyback Update

13 Aug '25

Executive Share Acquisition

12 Aug '25

Share Buyback Announcement

12 Aug '25

FDA Review Acceptance

11 Aug '25

Share Buyback Update

11 Aug '25

Patent Settlement

8 Aug '25

Share Buyback Announcement

8 Aug '25

Share Buyback Announcement

7 Aug '25

Share Buyback Announcement

6 Aug '25

Share Buyback Update

5 Aug '25

Share Buyback Announcement

4 Aug '25

Voting Rights Update

1 Aug '25

Share Buyback Process

1 Aug '25

Share Buyback Update

31 Jul '25

Strong 2Q Performance

30 Jul '25

Share Buyback Update

30 Jul '25

Share Buyback Announcement

29 Jul '25

New Collaboration

28 Jul '25

Share Buyback Update

28 Jul '25

Share Buyback Announcement

25 Jul '25

Blenrep Approval

24 Jul '25

Share Buyback Details

24 Jul '25

FDA Review Extended

23 Jul '25

Share Buyback Announcement

23 Jul '25

Share Buyback Update

22 Jul '25

Share Buyback Announcement

21 Jul '25

Share Acquisition Notification

18 Jul '25

FDA Advisory Committee Outcome

18 Jul '25

Share Buyback Announcement

18 Jul '25

Shingrix Approval

17 Jul '25

Share Buyback Process

17 Jul '25

Share Buyback Announcement

16 Jul '25

Share Acquisitions

15 Jul '25

Share Buyback Update

15 Jul '25

Share Acquisitions

14 Jul '25

FDA Review Submission

14 Jul '25

Share Buyback Update

14 Jul '25

Share Buyback Details

11 Jul '25

Share Buyback Announcement

10 Jul '25

Share Buyback Announcement

9 Jul '25

Share Buyback

8 Jul '25

GSK Acquisition Complete

7 Jul '25

Share Buyback Program

7 Jul '25

Share Buyback

7 Jul '25

Share Buyback Update

3 Jul '25

Share Buyback Announcement

2 Jul '25

Voting Rights Update

1 Jul '25

Share Buyback Update

1 Jul '25

Share Buyback Update

30 Jun '25

Share Buyback Activity

27 Jun '25

Share Buyback Update

26 Jun '25

Share Buyback Update

25 Jun '25

Share Transactions

24 Jun '25

Director Appointment

24 Jun '25

Share Buyback Acquisition

24 Jun '25

Share Purchases Revealed

23 Jun '25

Drug Review Accepted

23 Jun '25

Share Buyback Update

23 Jun '25

RSV Vaccine Update

20 Jun '25

Share Buyback Program

20 Jun '25

Share Buyback Update

20 Jun '25

Share Buyback Announcement

18 Jun '25

Share Buyback Update

17 Jun '25

Share Buyback Announcement

16 Jun '25

Share Sale Notification

13 Jun '25

Share Buyback Program

13 Jun '25

RSV Vaccine Update

13 Jun '25

Director Shareholding

12 Jun '25

Share Buyback Update

12 Jun '25

Share Sale Notification

11 Jun '25

Share Buyback Update

11 Jun '25

Share Buyback Program

10 Jun '25

Share Buyback Announcement

9 Jun '25

Share Buyback Announcement

6 Jun '25

Share Buyback Update

5 Jun '25

Share Buyback Announcement

4 Jun '25

Share Buyback Announcement

4 Jun '25

Share Buyback Announcement

3 Jun '25

Share Sale Notification

2 Jun '25

Voting Rights Update

2 Jun '25

FDA Review Acceptance

2 Jun '25

Share Buyback Report

2 Jun '25

Share Buyback Report

30 May '25

Share Buyback Announced

29 May '25

Trial Stopped Early

28 May '25

Share Buyback Announcement

28 May '25

Share Buyback Announcement

27 May '25

Positive CHMP Opinion

23 May '25

FDA Approval News

23 May '25

Share Buyback Announced

23 May '25

Share Buyback Update

22 May '25

Share Buyback Activity

21 May '25

Shareholding Update

20 May '25

Share Buyback Announcement

20 May '25

Blenrep Approval

19 May '25

Share Buyback Announcement

19 May '25

Share Buyback Announcement

16 May '25

Share Buyback Announcement

15 May '25

GSK Acquisition Announcement

14 May '25

Share Buyback Announcement

14 May '25

Share Acquisitions

13 May '25

Belrestotug Development Ended

13 May '25

Share Buyback Update

13 May '25

Block Listing Update

12 May '25

Share Buyback Update

12 May '25

Share Buyback Update

9 May '25

CEO Share Award

8 May '25

Share Vesting Update

8 May '25

Linerixibat Trial Results

8 May '25

Share Buyback Update

8 May '25

AGM Results Report

7 May '25

Share Buyback Announcement

7 May '25

Share Buyback Announcement

6 May '25

Share Buyback Announcement

2 May '25

Director Shareholding

1 May '25

Voting Rights Update

1 May '25

Positive Trial Results

1 May '25

Share Buyback Announcement

1 May '25

Share Buyback Announcement

30 Apr '25

Q1 2025 Results

30 Apr '25

Share Buyback Announcement

29 Apr '25

Share Buyback Update

28 Apr '25

Share Buyback Completed

25 Apr '25

Share Buyback Update

24 Apr '25

Share Buyback Activity

23 Apr '25

Share Buyback Announcement

22 Apr '25

Blenrep Approval

17 Apr '25

Dividend Reinvestment

17 Apr '25

RSV Vaccine Recommendation

17 Apr '25

Vaccine Recommendation

17 Apr '25

Share Buyback Update

17 Apr '25

Share Buyback Update

16 Apr '25

Share Acquisitions

15 Apr '25

Share Buyback Update

15 Apr '25

Director Share Acquisitions

14 Apr '25

Share Buyback Announcement

14 Apr '25

Director Share Acquisitions

11 Apr '25

Share Buyback Announcement

11 Apr '25

Share Buyback Announcement

10 Apr '25

Share Purchase Announcement

9 Apr '25

Share Buyback Announcement

8 Apr '25

Share Buyback Announcement

7 Apr '25

Share Buyback Announcement

4 Apr '25

Share Buyback Announcement

3 Apr '25

Share Buyback Announcement

2 Apr '25

Voting Rights Update

1 Apr '25

Share Repurchase Announcement

1 Apr '25

Share Buyback Announcement

31 Mar '25

Director Shareholding Changes

28 Mar '25

Share Buyback Announcement

28 Mar '25

Share Buyback Announcement

27 Mar '25

Share Buyback Announcement

26 Mar '25

FDA Approval Announcement

25 Mar '25

Share Buyback Announcement

25 Mar '25

AGM Notice Issued

24 Mar '25

Nucala Review Acceptance

24 Mar '25

Share Buyback Details

24 Mar '25

Director Shareholding

21 Mar '25

Share Buyback Update

21 Mar '25

Share Buyback Announcement

20 Mar '25

Share Buyback Program

19 Mar '25

Share Buyback Announcement

18 Mar '25

Share Buyback Announcement

17 Mar '25

Share Transactions

14 Mar '25

Buyback Announcement

14 Mar '25

Filing Notification

13 Mar '25

Share Buyback Announcement

13 Mar '25

Share Buyback Update

12 Mar '25

Share Buyback

11 Mar '25

Share Buyback Announcement

10 Mar '25

Share Buyback Update

7 Mar '25

Share Buyback Update

6 Mar '25

Share Buyback Report

5 Mar '25

Share Buyback Announcement

4 Mar '25

Annual Report Filing

3 Mar '25

Voting Rights Update

3 Mar '25

FDA Review Accepted

3 Mar '25

Clinical Trial Results

3 Mar '25

Share Buybacks Announcement

3 Mar '25

Share Buyback Announcement

28 Feb '25

Share Buyback Announcement

27 Feb '25

Annual Report Released

27 Feb '25

Director Transactions

26 Feb '25

Share Buyback Announcement

26 Feb '25

Share Buyback Plan

25 Feb '25

Acquisition Completed

24 Feb '25

Share Buyback Programme

24 Feb '25

Board Change Announced

21 Feb '25

Share Awards Granted

21 Feb '25

Bonus Awards Granted

21 Feb '25

Shareholding Update

21 Feb '25

Share Vesting Report

21 Feb '25

Share Vesting Notification

21 Feb '25

Executive Share Transactions

21 Feb '25

Nucala Drug Update

20 Feb '25

Vaccine Approval

18 Feb '25

Share Transactions

13 Feb '25

Share Vesting Report

11 Feb '25

Strong 2024 Results

5 Feb '25

Voting Rights Update

3 Feb '25

New Drug Review

28 Jan '25

EMA Review Accepted

28 Jan '25

Shingrix Review Accepted

27 Jan '25

Jemperli Approval Expansion

21 Jan '25

Share Acquisition Report

16 Jan '25

Shareholding Increase

15 Jan '25

Share Acquisitions

14 Jan '25

Share Acquisition Details

13 Jan '25

GSK Acquisition News

13 Jan '25

Shingrix FDA Review

10 Jan '25

FDA Breakthrough Designation

7 Jan '25

Nucala Approved

3 Jan '25

Voting Rights Update

2 Jan '25

Director Share Purchases

23 Dec '24

Block Listing Application

20 Dec '24

Trial Results Announced

20 Dec '24

FDA Designation Granted

16 Dec '24

EMA Designation Granted

16 Dec '24

Positive Approval Opinion

16 Dec '24

Director Shareholding Update

12 Dec '24

Blenrep Success

9 Dec '24

Regulatory Acceptance

9 Dec '24

FDA Submission Accepted

9 Dec '24

Vaccine Collaboration Extended

5 Dec '24

Transaction Notification

2 Dec '24

Voting Rights Update

2 Dec '24

Vaccine Approval

27 Nov '24

FDA Review Accepted

25 Nov '24

RSV Vaccine Approval

22 Nov '24

Share Acquisition Report

19 Nov '24

Linerixibat Success

19 Nov '24

Survival Results Announced

14 Nov '24

Block Listing Review

13 Nov '24

Director Share Transactions

12 Nov '24

Dividend Dates Announced

12 Nov '24

Voting Rights Update

1 Nov '24

Shareholding Update

30 Oct '24

Q3 2024 Results

30 Oct '24

RSV Vaccine Update

24 Oct '24

Director Shareholdings

17 Oct '24

Share Acquisitions

16 Oct '24

FDA Approval News

16 Oct '24

Director Shareholding Update

15 Oct '24

ANCHOR Trials Results

15 Oct '24

Share Acquisitions

11 Oct '24

Share Acquisition

10 Oct '24

Zantac Litigation Settlements

9 Oct '24

Positive Vaccine Data

8 Oct '24

Voting Rights Update

1 Oct '24

Director Share Purchases

24 Sep '24

Positive Vaccine Opinion

24 Sep '24

Zantac Settlements

18 Sep '24

Regulatory Review Accepted

17 Sep '24

Blenrep Therapy Designation

13 Sep '24

Director Shareholding

12 Sep '24

Positive Vaccine Results

12 Sep '24

Zantac Settlement

11 Sep '24

Office Relocation

11 Sep '24

HSV Vaccine Update

11 Sep '24

Asthma Treatment Breakthrough

9 Sep '24

Share Award Notification

6 Sep '24

Nucala Trial Success

6 Sep '24

Total Voting Rights

3 Sep '24

EMA Approval Announcement

29 Aug '24

Nucala Approved

28 Aug '24

SENKU Designation Granted

28 Aug '24

Zantac Litigation Update

28 Aug '24

Director Shareholding

21 Aug '24

Director Shareholding

20 Aug '24

FDA Designation Granted

20 Aug '24

Court Ruling Favor

16 Aug '24

Share Acquisition Report

12 Aug '24

Litigation Verdict

6 Aug '24

Jemperli Approval Expanded

2 Aug '24

Voting Rights Update

1 Aug '24

Strong Q2 Performance

31 Jul '24

Zantac Litigation Update

29 Jul '24

Positive Vaccine Opinion

29 Jul '24

EMA Review Accepted

19 Jul '24

External Links:

SEC

On March 16, 2026, GSK plc bought back 628,000 ordinary shares at prices ranging from 2,026.00p to 2,052.00p, continuing their buyback program initiated on February 17, 2026; they now hold a total of 250,444,503 shares as treasury shares.

AI Assistant

GSK PLC

2026

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.